Cleared Traditional

K201939 - GAIA Lumbar Interbody Fusion Device (LI...

K201939 is the FDA 510(k) clearance for GAIA Lumbar Interbody Fusion Device (LI... by Printerprezz. It is a Class 2 Orthopedic device (product code MAX) cleared through the Traditional 510(k) pathway after a 87-day FDA review.

K201939 · Printerprezz · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2020
Decision
87d
Days
Class 2
Risk

K201939 is an FDA 510(k) clearance for the GAIA Lumbar Interbody Fusion Device (LIFD) Family. Classified as Intervertebral Fusion Device With Bone Graft, Lumbar within the MAX classification (a category for intervertebral fusion devices and spinal implants), Class II - Special Controls.

Submitted by Printerprezz (Fremont, US). The FDA issued a Cleared decision on October 8, 2020 after a review of 87 days - a notably fast clearance cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3080 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Printerprezz devices

Submission Details

510(k) Number K201939 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 13, 2020
Decision Date October 08, 2020
Days to Decision 87 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
35d faster than avg
Panel avg: 122d · This submission: 87d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MAX Intervertebral Fusion Device With Bone Graft, Lumbar
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3080
Definition Intended To Stabilize Spinal Segment To Promote Fusion In Order To Restrict Motion And Decrease Pain Using Bone Graft.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Consultant

Empirical Testing Corp
Nathan Wright

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - MAX Intervertebral Fusion Device With Bone Graft, Lumbar

All 576
Devices cleared under the same product code (MAX) and FDA review panel - the closest regulatory comparables to K201939.
NuVasive Modulus XLIF Interbody System
K201692 · Nu Vasive, Incorporated · Oct 2020
Zavation IBF System
K200084 · Zavation Medical Products, LLC · Oct 2020
Zavation IBF System
K202305 · Zavation Medical Products, LLC · Oct 2020
Fortilink Cages with TiPlus Technology
K201453 · Paradigm Spine GmbH · Oct 2020
NuVasive® Cohere® Thoracolumbar Interbody System
K200953 · Nu Vasive, Incorporated · Oct 2020
NuVasive Thoracolumbar Interbody Systems: CoRoent Thoracolumbar System, CoRoent XL Interfixated System, Brigade Standalone System and Brigade Hyperlordotic System, Brigade Lateral System, BASE Interfixated Titanium System, Coalesce Thoracolumbar Interbody Fusion System, Cohere Thoracolumbar Interbody System, Modulus XLIF Interbody System, Modulus TLIF Interbody System, 3DP Interfixated ALIF System
K201820 · Nu Vasive, Incorporated · Sep 2020